// App-Quantinova.ai

4816 : Overexpressed A20 in Refractory/Relapse B-ALL May Serve As a Potential Therapeutic Target

Researchers

Presenter

  • Xiuli Wu

Principal Investigators

  • Fan Zhang

  • Sichu Liu

  • Shaohua Chen

  • Lijian Yang

  • Bo Li

  • Yangqiu Li

Medical Centers

  • Institute of Hematology, Medical College, Jinan University, Guangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • B-cell acute lymphoblastic leukemia

  • Acute lymphoblastic leukemia

  • B lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Prostate cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Tumor necrosis factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim